Idera Pharmaceuticals (IDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDRA | AZN | AMGN | GILD | BMY |
| Company | Idera Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.4800 | 181.48 | 321.91 | 132.84 | 57.00 |
| High | 0.5100 | 181.98 | 324.11 | 133.65 | 57.48 |
| Low | 0.4200 | 180.00 | 320.52 | 131.89 | 56.79 |
| Latest | 0.4250 | 181.28 | 321.69 | 133.10 | 56.86 |
| Change | -0.1169 | -2.18 | -2.16 | +0.41 | -0.52 |
| % Change | -21.57% | -1.19% | -0.67% | +0.31% | -0.91% |
| Volume | 371,800 | 1,473,553 | 738,562 | 1,566,687 | 3,712,538 |
| 20-Day Average Volume | 308,970 | 1,961,480 | 2,496,912 | 5,238,396 | 9,645,687 |
| Previous Close | 0.5419 | 183.46 | 323.85 | 132.69 | 57.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4095 | 194.82 | 344.21 | 134.91 | 58.61 |
| 20-Day Raw Stochastic | 41.58% | 6.15% | 4.68% | 34.70% | 1.42% |
| 20-Day Relative Strength | 51.01 | 36.97 | 35.15 | 43.81 | 44.77 |
| Weighted Alpha | -72.05 | +26.30 | +14.17 | +29.47 | +22.70 |
| Today's Opinion | 8% Buy | 8% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -35.11% since 01/09/23 | -2.68% since 04/28/26 | -5.07% since 04/28/26 | +2.86% since 04/28/26 | -2.24% since 04/28/26 |
| Low | 0.4200 on 01/17/23 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 56.90 on 05/05/26 |
| High | 0.7000 on 01/10/23 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 133.62 on 05/05/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +57.41% since 12/16/22 | -10.72% since 04/02/26 | -7.36% since 04/02/26 | -4.83% since 04/02/26 | -4.44% since 04/02/26 |
| Low | 0.2150 on 12/28/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.90 on 05/05/26 |
| High | 0.7200 on 01/06/23 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +20.81% since 10/17/22 | -2.93% since 02/05/26 | -12.36% since 02/05/26 | -10.99% since 02/05/26 | -4.31% since 02/05/26 |
| Low | 0.2150 on 12/28/22 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 0.7200 on 01/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -1.46% since 07/15/22 | +11.94% since 11/05/25 | +0.78% since 11/05/25 | +8.47% since 11/05/25 | +22.56% since 11/05/25 |
| Low | 0.2150 on 12/28/22 | 166.74 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.7200 on 01/06/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,501 | 284,529,568 | 174,776,976 | 164,697,760 | 117,154,760 |
| Shares Outstanding, K | 62,355 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 98,090,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 50,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -3,100,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.25 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/14/22 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/30/23 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.95 | 14.92 | 16.15 | 9.82 |